FindTrial
Sign In

A RANDOMIZED DOUBLE BLIND ACTIVE CONTROLLED PARALLEL TRIAL TO COMPARE THE EFFECT OF INHALATION OF COOLER AIR(OF DIFFERENT TEMPERATURES 18-22°c,23-27°c AND 28-30°c)WITH WARMER AIR(33-37°c)ON SYMPTOMS AND LUNG FUNCTIONS IN PATIENTS WITH BRONCHIAL ASTHMA OF MILD SEVERITY

A CLINICAL TRIAL TO SEE THE EFFECT OF INHALATION OF AIR OF DIFFERENT TEMPERATURE IN PATIENTS WITH BRONCHIAL ASTHMA OF MILD SEVERITY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2009/091/000701
Enrollment
150
Registered
2009-09-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: INHALATION OF COOLER AIR 18-22&deg
c,23-27&deg
c AND 28-30&deg
c IN AIR C0NDITIONED ROOM: THREE SEPARATE SUBGROUPS OF GROUP 2 WILL GET INHALATION OF COOLER AIR. SUBGROUP 2A WILL BE EXPOSED TO 18-22&deg
c,SUBGROUP 2B TO 23-27&deg
cAND SUBGROUP 2C TO 28-30&deg
c.THE INHALATION WIL BE OF 2 MINUTES DAILY DURING FIRST WEEK.SECOND WEEK 5 MINUTES DAILY, THIRD WEEK 10 MINUTES DAILY, FOURTH WEEK 15 MINUTES DAILY, FIFTH WEEK 20 MINUTES DAILY AND SIXTH WEEK 30 MINUT
c IN AIR CONDITIONED ROOM: INHALATION WILL BE OF 2 MINUTES DAILY DURING FIRST WEEK, FIVE MINUTES IN SECOND WEEK, 10 MINUTES IN THIRD WEEK, 15 MINUTES IN FOURTH WEEK,20 MINUTES IN FIFTH WEEK AND 30 MIN

Sponsors

MITTAL HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ADULT MALES AND FEMALES AGE 24-46 YEARS WITH MILD BRONCHIAL ASTHMA (FEv1=/>80% with PEFR REVERSIBILITY <20%) WITH INTERMITTENT SYMPTOMS

Exclusion criteria

Exclusion criteria: HISTORY OF IHD, CHRONIC RESPIRATORY INFECTIONS, ANEMIA, MODERATE BRONCHIAL ASTHMA(FEv1 <60-80%)

Design outcomes

Primary

MeasureTime frame
CHANGES IN PEFR AND FEv1Timepoint: AT THE END OF THIRD AND SIXTH WEEK—

Secondary

MeasureTime frame
IMPROVEMENT/NO CHANGE/DETERIORATION IN FOUR SYMPTOMS COUGH,BREATHLESSNES, WHEEZING,CHEST HEAVINESSTimepoint: WEEKLY—

Countries

India

Contacts

Public ContactMANJARI SAXENA
yogdiab@gmail.com0145 2603600

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026